La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Qlucore Gestione

Gestione criteri di controllo 2/4

Qlucore's Il CEO è Carl-Johan Ivarsson, nominato in Jan2007, ha un mandato di 17.58 anni. possiede direttamente 8.6% delle azioni della società, per un valore di € 231.77K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 10 anni e 5.6 anni.

Informazioni chiave

Carl-Johan Ivarsson

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	17.7yrs
Proprietà del CEO	8.6%
Durata media del management	10.1yrs
Durata media del Consiglio di amministrazione	5.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Carl-Johan Ivarsson

17.7yrs

Mandato

Mr. Carl-Johan Ivarsson is Co-Founder, CEO & Director of Qlucore Ab (Publ) since 2007 and also serves as its Chair of Scientific Advisory Board since January 2022. Mr. Ivarsson has a master's degree in ele...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Carl-Johan Ivarsson	Chair of Scientific Advisory Board	17.7yrs	Nessun dato	8.6% SEK 181.0k
Thoas Fioretos	Co-Founder	17.7yrs	Nessun dato	4.58% SEK 96.3k
Johan Rade	Co-Founder	17.7yrs	Nessun dato	8.35% SEK 175.7k
Magnus Fontes	Member of Scientific Advisory Board	no data	Nessun dato	4.63% SEK 97.4k
Cecilia Grotte	Chief Financial Officer	2.6yrs	Nessun dato	Nessun dato
Ulf Ahlfors	Head of Research & Development	2.6yrs	Nessun dato	Nessun dato
Erik Soderback	Head of Diagnostics Sales	2.4yrs	Nessun dato	Nessun dato

10.1yrs

Durata media

Gestione esperta: Il team dirigenziale di 5QO è esperto e expertise (durata media dell'incarico 10 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Carl-Johan Ivarsson	Chair of Scientific Advisory Board	17.7yrs	Nessun dato	8.6% SEK 181.0k
Thoas Fioretos	Co-Founder	17.7yrs	Nessun dato	4.58% SEK 96.3k
Magnus Fontes	Member of Scientific Advisory Board	17.7yrs	Nessun dato	4.63% SEK 97.4k
Lars Hockenstrom	Independent Director	less than a year	Nessun dato	Nessun dato
Pia Magrhild Gideon	Independent Chairman	15.7yrs	Nessun dato	Nessun dato
Boel Sundvall	Independent Director	5.7yrs	Nessun dato	Nessun dato
Helle Fisker	Independent Director	2.6yrs	Nessun dato	Nessun dato
Albrecht Stenzinger	Member of Scientific Advisory Board	2.7yrs	Nessun dato	Nessun dato
Aurelien de Reynies	Member of Scientific Advisory Board	2.7yrs	Nessun dato	Nessun dato
Solange Peters	Member Scientific Advisory Board	no data	Nessun dato	Nessun dato

5.7yrs

Durata media

63.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 5QO sono considerati esperti (durata media dell'incarico 5.6 anni).

Qlucore Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Qlucore AB (publ), Annual General Meeting, Sep 09, 2024

High number of new directors

Less than half of directors are independent

Qlucore AB (Publ) Appoints Lars Höckenström as A Member of the Board of Directors

Qlucore Names Erik Söderbäck as Head of Diagnostics Sales

Qlucore AB (Publ) Appoints Helle Fisker as Regular Member of the Board

Recent updates

New major risk - Financial position

First quarter 2025 earnings released: kr1.87 loss per share (vs kr1.24 loss in 1Q 2024)

Qlucore AB (publ) to Report Q1, 2025 Results on Aug 29, 2024

New major risk - Share price stability

Full year 2024 earnings released: kr3.89 loss per share (vs kr3.96 loss in FY 2023)

Qlucore Starts Project After Receiving EU Grant to Advance Personalized Cancer Treatment

Third quarter 2024 earnings released: kr0.69 loss per share (vs kr0.72 loss in 3Q 2023)

Qlucore Diagnostics for Pediatric Leukemia Takes A Significant Step Closer to Ce Marking

Qlucore Announces Swedish Innovation Evaluated for Clinical Diagnosis of Pediatric Leukemia

Second quarter 2024 earnings released: kr0.81 loss per share (vs kr1.03 loss in 2Q 2023)

Qlucore AB (publ), Annual General Meeting, Sep 09, 2024

High number of new directors

Less than half of directors are independent

Qlucore AB (Publ) Appoints Lars Höckenström as A Member of the Board of Directors

First quarter 2024 earnings released: kr1.24 loss per share (vs kr1.20 loss in 1Q 2023)

New major risk - Share price stability

New major risk - Share price stability

Full year 2023 earnings released: kr3.96 loss per share (vs kr2.90 loss in FY 2022)

Qlucore AB (publ) to Report Q1, 2024 Results on Aug 30, 2023

Third quarter 2023 earnings released: kr0.72 loss per share (vs kr0.10 profit in 3Q 2022)

Second quarter 2023 earnings released: kr1.03 loss per share (vs kr1.62 loss in 2Q 2022)

Qlucore AB (publ) to Report First Half, 2023 Results on Nov 28, 2022

Qlucore Software Used in New Project to Prevent Cardiovascular Diseases

Qlucore Receives Patent in Europe

First quarter 2023 earnings released

Qlucore Expands Its Leukemia Diagnostics Solution

Qlucore Ab (Publ) to Report Q1, 2023 Results on Aug 30, 2022

Full year 2022 earnings released

Qlucore Names Erik Söderbäck as Head of Diagnostics Sales

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Qlucore AB (Publ) Appoints Helle Fisker as Regular Member of the Board

Qlucore Appoints Ulf Ahlfors as Head of R&D

Qlucore Announces Management Changes

Qlucore AB (publ) Announces Major New Release for Bioinformatics

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media

Età media